EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 142 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $891,071 | +62.0% | 102,422 | +330.5% | 0.02% | 0.0% |
| Q4 2023 | $549,879 | +40.5% | 23,794 | -51.4% | 0.02% | +20.0% |
| Q3 2023 | $391,254 | +284.4% | 48,968 | +318.5% | 0.02% | +275.0% |
| Q2 2023 | $101,790 | -24.6% | 11,700 | -31.6% | 0.00% | -20.0% |
| Q3 2022 | $135,000 | +3.8% | 17,100 | +3.6% | 0.01% | -16.7% |
| Q2 2022 | $130,000 | -33.7% | 16,500 | +2.5% | 0.01% | -25.0% |
| Q1 2022 | $196,000 | – | 16,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $42,580,000 | 6.66% |
| Stonepine Capital Management, LLC | 329,130 | $3,344,000 | 1.81% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 300,000 | $3,048,000 | 1.66% |
| ACUTA CAPITAL PARTNERS, LLC | 381,145 | $3,872,000 | 1.40% |
| Samsara BioCapital, LLC | 450,000 | $4,572,000 | 0.84% |
| Altium Capital Management LP | 289,316 | $2,939,000 | 0.82% |
| VR Adviser, LLC | 700,000 | $7,112,000 | 0.77% |
| Corriente Advisors, LLC | 200,000 | $2,032,000 | 0.75% |
| RA Capital Management | 1,250,000 | $12,700,000 | 0.19% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,181,200 | $12,001,000 | 0.18% |